← All trials
NCT03117751
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 29, 2017
- Primary completion
- Sep 30, 2026
- Completion date
- Mar 31, 2028
- First posted
- —
- Last posted
- —
- Enrollment
- 1000
- Arms / groups
- 8 / —
- Source
- AACT · pre-existing
Sponsors
- St. Jude Children's HospitalLead sponsor
- IncyteCollaborator
- St. Jude Children's HospitalOverall official - principal investigator
- Bristol-Myers SquibbCollaborator
- ShireCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.